About EvidentIQ
EvidentIQ is a company based in Hamburg (Germany) founded in 2021. EvidentIQ has completed 2 acquisitions, including Asthenis and Dacima Software. EvidentIQ offers products and services including EDC, eTMF, CTMS, and eCOA. EvidentIQ operates in a competitive market with competitors including Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
- Headquarter Hamburg, Germany
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website evidentiq.com
- Social LinkedIn YouTube
- Legal Name Evidentiq Group Gmbh
- Investments & AcquisitionsAsthenis
& 1 more
Products & Services of EvidentIQ
EvidentIQ offers a comprehensive portfolio of products and services, including EDC, eTMF, CTMS, and eCOA.
Software for electronic data capture in clinical trials
Platform for electronic trial master file management
System to accelerate trials and ensure data integrity
Tool for faster and reliable patient-reported outcomes
Apps and channels of EvidentIQ
its YouTube channel EvidentIQ Group has 68 subscribers and 23 videos.
Videos from EvidentIQ
The most watched videos on EvidentIQ's YouTube channel, EvidentIQ Group (68 subscribers). Click a video to play it here.
More on EvidentIQ Group.
People of EvidentIQ
8 people are tracked at EvidentIQ (6 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Andreas Weber | CEO | Leadership |
Dominique Manu | Group CEO | Leadership |
Erik Kolb | Chief Financial Officer | Leadership |
Manuel Neukum | Group Chief Operating Officer | Leadership |
Maurice Pustjens | Executive Director Operations & IT | Leadership |
J.david Renzelmann | Executive Director Business Development | Leadership |
Serdar Kusaksizoglu | Group Business Controller | Team |
Rupert Sedlmayr | Quality Manager | Team |
Complete people profiles for EvidentIQ
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EvidentIQ
EvidentIQ has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Asthenis and Dacima Software.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of oncological documentation systems | asthenis.de | Aschheim, Germany | 1998 | Sep 2023 | •••• | |
Offers electronic data capture software for clinical trials and studies. | dacimasoftware.com | Montreal, Canada | 2006 | Jul 2022 | •••• |
Complete acquisition details for EvidentIQ
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of EvidentIQ
3 dated milestones of EvidentIQ across 2 years, from founding to its latest funding, stage changes and deals.
- Founded EvidentIQ is founded.
- Acquisition Acquires Dacima Software.
- Acquisition Acquires Asthenis.
Competitors of EvidentIQ
EvidentIQ operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Medidata, Verily, TriNetX, Signant Health and WIRB-Copernicus Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medidata.com | 1999 | New York, United States | $41.5M | 1,677 | Medidata is recognized as a leading provider of SaaS solutions for clinical research. | |
| verily.com | 2015 | Dallas, United States | $2.5B | – | AI-based solutions for health management are provided. | |
| trinetx.com | 2013 | Cambridge, United States | $53M | 95 | Clinical trial management software is provided for researchers and professionals. | |
| signanthealth.com | 2000 | Plymouth Meeting, United States | $3.4M | – | Signant Health is engaged in providing clinical trial technology solutions. | |
| wcgclinical.com | 2012 | Princeton, United States | – | 229 | Regulatory and ethical review services for clinical research are provided. | |
| deep6.ai | 2013 | Pasadena, United States | $54.79M | 41 | AI enabled solutions for clinical trials | |
| clinicalink.com | 2006 | Winston-salem, United States | $13.15M | 283 | Paperless eSource and patient engagement solutions for clinical trials | |
| massivebio.com | 2014 | New York, United States | $14.13M | – | Provider of AI-based clinical trial management tool | |
| farohealth.com | 2019 | San Diego, United States | $35M | 20 | Faro Health is focused on digital clinical trial protocol design. |
Detailed competitors of EvidentIQ
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EvidentIQ
The website of EvidentIQ (evidentiq.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▲ 26.5% vs previous month
Latest news on Evidentiq
Complete news archive for EvidentIQ
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to EvidentIQ
10 companies that operate in the same segment as EvidentIQ (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EvidentIQ
EvidentIQ was founded in 2021.
EvidentIQ is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Andreas Weber is the current CEO of EvidentIQ.
EvidentIQ was founded in 2021 in Hamburg, Germany, as a provider of software solutions in the clinical trials sector. An integrated cloud platform is offered for clinical data management and patient centricity. Services include eCRF setup, pharmacovigilance management, protocol development, and data science support. Operations focus on streamlining trial processes across the industry.
EvidentIQ offers EDC, eTMF, CTMS, and eCOA.
EvidentIQ has made 2 acquisitions, including Asthenis, and Dacima Software.
EvidentIQ operates through Evidentiq Group Gmbh.